The Access to Medical Imaging Coalition (AMIC) today said that a study in the June 25 issue of the Journal of the American Medical Association (JAMA) digital breast tomosynthesis (3D mammography) underscores the value of ongoing research toward improved methods of detecting and treating invasive cancer.

The nidus mineralization ratio of osteoid osteomas increases significantly with pain duration and may be a marker of tumor age, according to a study published in the June issue of Radiology.

Digital breast tomosynthesis (DBT) has made the jump from a research technology to a clinically used technique, with nearly 30 percent of surveyed members from the Society of Breast Imaging reporting they use DBT.

The FDA has approved Bayer HealthCare’s Gadavist (gadobutrol) as the first intravenous MR contrast agent for evaluation of breast cancer in the U.S.

The role screening mammography should play has been debated for years—a debate that reached fever pitch following the shift in U.S. Preventive Services Task Force (USPSTF) guidelines in 2009—and the first half of 2014 has been no different.

The timing for performing breast MR diffusion-tensor imaging (DTI) is not restricted throughout the menstrual cycle, though the modulations in diffusion parameters due to hormone replacement therapy (HRT) and lactation should be taken into account in DTI evaluation, according to a study published in the June issue of Radiology.

Radiologic staff training may be an effective way to reduce radiation dose while preserving diagnostic image quality in pediatric head CT examinations, according to a study published in the June issue of the American Journal of Roentgenology.

Leading healthcare providers now have a scalable top-tier CT solution with the launch of Toshiba America Medical Systems, Inc.’s AquilionTM ONE Family.